The 340B Rebate Fight Escalates: 15 Key Developments

For more than a year, major drugmakers have been pushing to replace the 340B program’s longstanding upfront discount structure with post-sale rebate models – drawing resistance from hospitals and federal regulators at every stage.

What started as four lawsuits, in late 2024 has since expanded into a federal pilot program, a new wave of enforcement actions, and an unresolved legal battle still working through the courts.

Click Here to see the timeline of 15 key developments since the lawsuits were filed.